The Lancet, Band 368,Ausgabe 9547J. Onwhyn, 2006 |
Im Buch
Ergebnisse 1-3 von 82
Seite 1717
... Women Men Women Men Women Men Women 45-49 40-44 45-49 40-44 Age ( years ) 40-44 35-39 30-34 25-29 20-24 16-19 40-44 35-39 35-39 35-39 30-34 30-34 30-34 25-29 25-29 25-29 20-24 20-24 20-24 16-19 18-19 15-19 1000 750 500 Countries in ...
... Women Men Women Men Women Men Women 45-49 40-44 45-49 40-44 Age ( years ) 40-44 35-39 30-34 25-29 20-24 16-19 40-44 35-39 35-39 35-39 30-34 30-34 30-34 25-29 25-29 25-29 20-24 20-24 20-24 16-19 18-19 15-19 1000 750 500 Countries in ...
Seite 1889
... women were interviewed revealed that 69 % of the respondents knew one or more women who had died from an unsafe illegal abortion . " Focus - group discussions and community- based studies in India " revealed self - reported abortions in ...
... women were interviewed revealed that 69 % of the respondents knew one or more women who had died from an unsafe illegal abortion . " Focus - group discussions and community- based studies in India " revealed self - reported abortions in ...
Seite 2053
... women aged 50 years and older , but is less clear in younger women . A meta - analysis of all previous trials showed a 15 % mortality reduction in invited women aged 40-49 years at study entry , but this finding could be due in part to ...
... women aged 50 years and older , but is less clear in younger women . A meta - analysis of all previous trials showed a 15 % mortality reduction in invited women aged 40-49 years at study entry , but this finding could be due in part to ...
Inhalt
The LancetLondon | 1546 |
The future for specialists and the Medical Royal Colleges? 1619 Has the management of Alzheimers disease changed | 1559 |
Taking surgical services to rural Ecuador | 1563 |
Urheberrecht | |
4 weitere Abschnitte werden nicht angezeigt.
Andere Ausgaben - Alle anzeigen
Häufige Begriffe und Wortgruppen
abnormal activity acute myeloid leukemia administration adverse events adverse experiences ADVERSE REACTIONS amlodipine analysis ancrod antiretroviral therapy assessment associated atorvastatin atorvastatin calcium baseline CADUET cancer cardiovascular cholesterol cimetidine clinical trials condom contraceptive CONTRAINDICATIONS cytarabine deaths decreased developing countries digoxin discontinued disease Disorders drug effective coverage erythromycin estimates exenatide follow-up full prescribing information global health system HIV/AIDS hospital hypertension impaired increased infections insulin International interventions Lancet LDL-C levels levofloxacin LIPITOR liver metabolic mg/kg/day mortality myopathy obesity ondansetron oral outcomes patients receiving pharmacokinetics placebo plasma population potential pregnancy prevalence prevention programme PROVIGIL public health quinolones randomised rates rats reduction reported reproductive health rhabdomyolysis rimonabant risk factors Seguro Popular sexual and reproductive sexual behaviour sexually transmitted infections social Sonata South Africa stroke treated treatment tuberculosis type 2 diabetes unsafe abortion warfarin women World Health zaleplon ZOFRAN